Literature DB >> 7502102

AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic.

G V Stimson1.   

Abstract

This paper assesses policy development, service changes and trends in HIV infection and risk behavior among injecting drug users (IDUs) in the United Kingdom. In 1986, the U.K. was faced with the possible rapid spread of HIV infection among IDUs. The combination of an outbreak of HIV infection with prevalence levels of 50% or more in Edinburgh, the recent diffusion of drug injecting, and high levels of syringe-sharing risk behaviour, suggested that HIV infection might spread rapidly through IDU populations. HIV prevention activities commenced in 1986 and developed in 1987. The first report on AIDS and Drugs Misuse by the Advisory Council on the Misuse of Drugs in 1988 was a major catalyst for change. It supported and legitimized emergent views on new ways of working with drug users. Between 1988 and 1993 innovative public health projects increased the ability to target vulnerable populations through syringe distribution, expansion of methadone treatment and outreach to hard-to-reach populations. There were major changes in service philosophy and practices, as ideas of harm minimization, accessibility, flexibility and multiple and intermediate goals were developed. There is evidence that these public health projects encouraged extensive changes in the health behaviour of IDUs. There have been major reductions in syringe-sharing risk behaviour and sharing syringes is no longer the norm. Evaluation of specific interventions (e.g. syringe-exchange) shows their importance in encouraging reductions in risk behaviour. Levels of HIV infection in IDUs remain low by international standards. Outside of London rates of about 1% have been reported; London has a low and declining prevalence of infection to around 7% in 1993; previous high levels in Edinburgh (55%) have since declined to 20%. Britain has to date avoided the rapid increase in HIV infection among injectors that has occurred in many parts of the world. The same period saw the continuation of high prevalence levels in New York and many European cities, and the explosive spread of HIV in many countries in south-east Asia. This paper acknowledges the difficulties is proving links between social interventions and epidemic prevention. It argues that there is prima facie evidence for the success of public health prevention, that the collection of intervention approaches in the U.K. had a significant impact on IDUs behaviour, and that this has helped prevent an epidemic of HIV infection among IDUs. The U.K. experience adds to the growing evidence of the significance of early interventions in encouraging behaviour change and in limiting the spread of HIV infection.

Entities:  

Mesh:

Year:  1995        PMID: 7502102     DOI: 10.1016/0277-9536(94)00435-v

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  18 in total

1.  High risk injecting behaviour among injectors from Glasgow: cross sectional community wide surveys 1990-1999.

Authors:  A Taylor; D Goldberg; S Hutchinson; S Cameron; R Fox
Journal:  J Epidemiol Community Health       Date:  2001-10       Impact factor: 3.710

2.  Diffusion of the D.A.R.E and syringe exchange programs.

Authors:  Don C Des Jarlais; Zili Sloboda; Samuel R Friedman; Barbara Tempalski; Courtney McKnight; Naomi Braine
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

3.  Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Holly Hagan
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

4.  Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?

Authors:  David C Perlman; Don C Des Jarlais; Jonathan Feelemyer
Journal:  J Addict Dis       Date:  2015

5.  State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness.

Authors:  Heidi Bramson; Don C Des Jarlais; Kamyar Arasteh; Ann Nugent; Vivian Guardino; Jonathan Feelemyer; Derek Hodel
Journal:  J Public Health Policy       Date:  2015-01-15       Impact factor: 2.222

6.  Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis.

Authors:  Manon Ragonnet-Cronin; Celia Jackson; Amanda Bradley-Stewart; Celia Aitken; Andrew McAuley; Norah Palmateer; Rory Gunson; David Goldberg; Catriona Milosevic; Andrew J Leigh Brown
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

7.  Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.

Authors:  Elizabeth C Costenbader; William A Zule; Curtis C Coomes
Journal:  Int J Drug Policy       Date:  2010-01-22

8.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

9.  Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention.

Authors:  Pedro Mateu-Gelabert; Shana Harris; Dedsy Berbesi; Ángela María Segura Cardona; Liliana Patricia Montoya Vélez; Inés Elvira Mejía Motta; Lauren Jessell; Honoria Guarino; Samuel R Friedman
Journal:  Subst Use Misuse       Date:  2016-01-22       Impact factor: 2.164

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.